ONYX PHARMACEUTICALS INC Contracts Revenue (Deprecated 2018-01-31)
ONYX PHARMACEUTICALS INC reported Contracts Revenue (Deprecated 2018-01-31) of $81.83 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Income Statement › Other Income
us-gaap:ContractsRevenue · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC contracts revenue (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $81.83M, a 12.55% increase year-over-year.
- ONYX PHARMACEUTICALS INC contracts revenue (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $70.31M, a 2.39% decline year-over-year.
- ONYX PHARMACEUTICALS INC contracts revenue (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $72.94M, a 5.06% decline year-over-year.
- ONYX PHARMACEUTICALS INC contracts revenue (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $70.74M, a 5.73% decline year-over-year.
- ONYX PHARMACEUTICALS INC contracts revenue (deprecated 2018-01-31) for fiscal 2012 was $288.42M, a 0.51% increase from fiscal 2011.
- ONYX PHARMACEUTICALS INC contracts revenue (deprecated 2018-01-31) for fiscal 2011 was $286.96M, a 8.15% increase from fiscal 2010.
- ONYX PHARMACEUTICALS INC contracts revenue (deprecated 2018-01-31) for fiscal 2010 was $265.35M, a 5.97% increase from fiscal 2009.
- ONYX PHARMACEUTICALS INC contracts revenue (deprecated 2018-01-31) for fiscal 2009 was $250.39M.
| Period end | Contracts Revenue (Deprecated 2018-01-31) 3 month | Contracts Revenue (Deprecated 2018-01-31) 6 month | Contracts Revenue (Deprecated 2018-01-31) 9 month | Contracts Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2013-06-30 | $81.83M 10-Q · filed 2013-08-09 | $152.13M 10-Q · filed 2013-08-09 | $225.07M derived: sum of 3 quarters · filed 2013-08-09 | $295.81M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $70.31M 10-Q · filed 2013-05-08 | $143.24M derived: sum of 2 quarters · filed 2013-05-08 | $213.99M derived: sum of 3 quarters · filed 2013-05-08 | $286.69M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $72.94M 10-K · filed 2013-02-28 | $143.68M derived: sum of 2 quarters · filed 2013-02-28 | $216.38M derived: sum of 3 quarters · filed 2013-08-09 | $288.42M 10-K · filed 2013-02-28 |
| 2012-09-30 | $70.74M 10-K · filed 2013-02-28 | $143.45M derived: sum of 2 quarters · filed 2013-08-09 | $215.48M 10-Q · filed 2012-11-02 | $292.30M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $72.70M 10-Q · filed 2013-08-09 | $144.74M 10-Q · filed 2013-08-09 | $221.56M derived: sum of 3 quarters · filed 2013-08-09 | $296.60M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $72.03M 10-Q · filed 2013-05-08 | $148.85M derived: sum of 2 quarters · filed 2013-05-08 | $223.89M derived: sum of 3 quarters · filed 2013-05-08 | $291.85M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | $76.82M 10-K · filed 2013-02-28 | $151.86M derived: sum of 2 quarters · filed 2013-02-28 | $219.82M derived: sum of 3 quarters · filed 2013-02-28 | $286.96M 10-K · filed 2013-02-28 |
| 2011-09-30 | $75.04M 10-K · filed 2013-02-28 | $143.00M derived: sum of 2 quarters · filed 2013-02-28 | $210.14M 10-Q · filed 2012-11-02 | $280.12M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $67.96M 10-K · filed 2013-02-28 | $135.10M 10-Q · filed 2012-08-06 | $205.08M derived: sum of 3 quarters · filed 2013-02-28 | $268.77M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $67.14M 10-K · filed 2013-02-28 | $137.12M derived: sum of 2 quarters · filed 2013-02-28 | $200.82M derived: sum of 3 quarters · filed 2013-02-28 | $269.59M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | $69.98M 10-K · filed 2012-02-27 | $133.67M derived: sum of 2 quarters · filed 2012-02-27 | $202.45M derived: sum of 3 quarters · filed 2012-02-27 | $265.35M 10-K · filed 2013-02-28 |
| 2010-09-30 | $63.70M 10-K · filed 2012-02-27 | $132.47M derived: sum of 2 quarters · filed 2012-02-27 | $195.37M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $68.77M 10-K · filed 2012-02-27 | $131.68M 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | $62.90M 10-K · filed 2012-02-27 | |||
| 2009-12-31 | $250.39M 10-K · filed 2012-02-27 |